Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Lipocine Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- +5 vs. Q4 2021
- Shares held
- 11.9M
- +1.30M (+12.2%) vs. Q4 2021
- Total value
- $16.2M
- +$5.64M (+53.6%) vs. Q4 2021
- New holders
- 9
- 13 more added
- Sold out
- 4
- 9 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LPCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $7.63M |
| Q1 2026 | 47 | $24.9M |
| Q4 2025 | 26 | $13.1M |
| Q3 2025 | 22 | $1.51M |
| Q2 2025 | 18 | $1.67M |
| Q1 2025 | 19 | $1.65M |
| Q4 2024 | 17 | $2.38M |
| Q3 2024 | 18 | $2.44M |
| Q2 2024 | 19 | $4.38M |
| Q1 2024 | 18 | $2.46M |
| Q4 2023 | 19 | $1.35M |
| Q3 2023 | 21 | $1.48M |
| Q2 2023 | 24 | $2.40M |
| Q1 2023 | 45 | $3.17M |
| Q4 2022 | 49 | $4.16M |
| Q3 2022 | 46 | $4.85M |
| Q2 2022 | 46 | $9.54M |
| Q1 2022 | 44 | $16.2M |
| Q4 2021 | 39 | $10.5M |
| Q3 2021 | 38 | $10.0M |
| Q2 2021 | 33 | $12.8M |
| Q1 2021 | 42 | $12.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Lipocine Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 140 | $0 | 0.00% | −46−24.7% | Reduced |
| Walleye Trading LLC | 101 | $0 | 0.00% | +101 | New |
| Bank of America Corp | 1,000 | $1.00K | 0.00% | −167−14.3% | Reduced |
| Citigroup Inc | 500 | $1.00K | 0.00% | +500 | New |
| Benjamin F. Edwards & Company, Inc. | 1,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 3,543 | $5.00K | 0.00% | −569−13.8% | Reduced |
| UBS Group AG | 7,362 | $10.0K | 0.00% | +3,362+84.1% | Added |
| Tower Research Capital LLC (TRC) | 8,554 | $12.0K | 0.00% | +5,995+234.3% | Added |
| Creative Planning | 10,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 13,900 | $19.0K | 0.00% | +900+6.9% | Added |
| Renaissance Technologies LLC | 14,100 | $19.0K | 0.00% | +14,100 | New |
| Plante Moran Financial Advisors, LLC | 17,000 | $23.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 18,905 | $26.0K | 0.00% | +18,905 | New |
| Moloney Securities Asset Management, LLC | 22,500 | $31.0K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 29,899 | $41.0K | 0.00% | −135,078−81.9% | Reduced |
| Jane Street Group, LLC | 30,759 | $42.0K | 0.00% | +8,121+35.9% | Added |
| XTX Topco Ltd | 39,357 | $54.0K | 0.02% | +39,357 | New |
| Morgan Stanley | 40,823 | $55.0K | 0.00% | −185,425−82.0% | Reduced |
| Charles Schwab Investment Management Inc | 50,000 | $69.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 55,204 | $76.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 63,135 | $86.0K | 0.00% | +27,530+77.3% | Added |
| RSM US Wealth Management LLC | 65,212 | $89.0K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 66,500 | $91.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 70,250 | $96.0K | 0.00% | +7,500+12.0% | Added |
| MML Investors Services, LLC | 77,000 | $105.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 88,615 | $121.0K | 0.00% | +74,428+524.6% | Added |
| Virtu Financial LLC | 124,550 | $171.0K | 0.01% | +7,064+6.0% | Added |
| Two Sigma Advisers, LP | 142,400 | $195.0K | 0.00% | +89,400+168.7% | Added |
| Northern Trust Corp | 168,225 | $230.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 176,864 | $242.0K | 0.00% | +176,864 | New |
| Price T Rowe Associates Inc | 184,662 | $253.0K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 307,300 | $421.0K | 0.00% | +67,000+27.9% | Added |
| Mercer Global Advisors Inc | 309,111 | $423.0K | 0.00% | −4,000−1.3% | Reduced |
| State Street Corp | 327,405 | $449.0K | 0.00% | +22,788+7.5% | Added |
| Two Sigma Investments, LP | 360,070 | $493.0K | 0.00% | +257,470+250.9% | Added |
| Marshall Wace, LLP | 562,670 | $771.0K | 0.00% | +562,670 | New |
| EAM Investors, LLC | 657,804 | $901.0K | 0.17% | +657,804 | New |
| Geode Capital Management, LLC | 823,055 | $1.13M | 0.00% | −1,379−0.2% | Reduced |
| Wealth Effects LLC | 1,490,834 | $2.04M | 0.95% | +1,400+0.1% | Added |
| BlackRock Inc. | 1,564,692 | $2.14M | 0.00% | −29,855−1.9% | Reduced |
| Vanguard Group Inc | 3,797,282 | $5.20M | 0.00% | −12,688−0.3% | Reduced |
| Aaron Wealth Advisors | 117,552 | – | – | +117,552 | New |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −440,432−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −24,180−100.0% | Sold out |
| Pinnacle Private Wealth, LLC | 0 | $0 | 0.00% | −15,250−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −11,715−100.0% | Sold out |